Julphar Bangladesh Ltd. Julphar Bangladesh Ltd.

Julphar Bangladesh Launched latest Methylxanthine- Doxair (Doxophylline 400 mg Tablet)

Julphar Bangladesh has launched another breakthrough Molecule Doxair (Doxophylline 400 mg Tablet) for Better management of Asthma & COPD

  • Provides both Bronchodilatory and Anti-inflammatory effect
  • Shows outstanding efficacy in Asthma & COPD
  • Ensures Cardiac safety
  • Ensures normal sleep
  • Ensures Renal & GI safety
  • DMF grade best quality API

Dosage guideline:

1 tablet once daily in the evening. Dose may be increased up to 1 tablet thrice daily depend on response.

Child > 6 years: 6 mg/kg twice daily. The dose may be increased up to 18 mg/kg daily on the basis of medical response.


Last Update: 23 Jan 2018

© Julphar Bangladesh Ltd. 2008 - 2018. All Rig hts Reserved.
Developed By : Alien BD Inforamtion & Technology